Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ECT-001 Expanded Cord Blood Transplant in High-risk Multiple Myeloma
NCT03441958Phase 2Completed
- Start
- Mar 2018
- Primary completion
- Oct 2023
- Modality
- Stem Cell Therapies
- Countries
- 1
01
Overview
A Phase 2 trial of dorocubicel in multiple myeloma (MM). Started Mar 2018; status: completed.
02
Drugs
dorocubicel
03
Conditions
multiple myeloma (MM)
Beyond the preview
Go deeper on NCT03441958.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03441958.